신라젠 CI.관련 키워드신라젠혈액암 신약 도전급성 골수성 백혈병임상 승인FDA문대현 기자 Kangstem Biotech CSO Professor Kang Kyung-sun Confirms Therapeutic Potential of Vascularized Artific...Beyond Approval to Insurance Coverage: Medical AI Companies Turn to Real-World Evidence to Drive Ado...
